Company Filing History:
9 out of 42 
3 out of 216 
1 out of 48 
Years Active: 2009-2016
Title: Mark Staples: Innovator in Liquid Formulations and Modified Pectins
Introduction
Mark Staples is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of biopharmaceuticals. With a total of 14 patents to his name, he has made remarkable advancements in the formulation of liquid interferon and modified pectins. His work has had a substantial impact on the development of therapeutic compositions.
Latest Patents
One of Mark Staples' latest patents is focused on stable liquid interferon beta formulations. This invention describes liquid interferon compositions with a pH range between 4.0 and 7.2, which include interferon-beta and a stabilizing agent. The stabilizing agent is an amino acid selected from a specific group, and the composition may include salt to ensure sufficient ionic strength. Notably, the liquid composition has not been previously lyophilized or cavitated, and it is contained within a vessel that has a surface coated with a material that does not adsorb interferon-beta. Additionally, he has developed a kit for parenteral administration of this liquid formulation and a method for stabilizing such compositions. Another significant patent involves modified pectins, providing compositions and methods for their preparation and use.
Career Highlights
Throughout his career, Mark Staples has worked with notable companies in the biopharmaceutical sector, including La Jolla Pharmaceutical Company and Biogen Idec. His expertise in the field has allowed him to contribute to innovative solutions that address critical health challenges.
Collaborations
Mark has collaborated with several professionals in his field, including James Rolke and Mary Diana DiBiase. These collaborations have further enhanced his research and development efforts.
Conclusion
Mark Staples is a distinguished inventor whose work in liquid formulations and modified pectins continues to influence the biopharmaceutical industry. His innovative patents and collaborations reflect his commitment to advancing medical science.